The HFE gene heterozygosis H63D: A cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations

Internal Medicine Journal

Volumn 38, Issue 4, 2008, Pages 254-258

  Neri, S ^a   Pulvirenti, D ^a   Signorelli, S ^a   Ignaccolo, L ^a   Tsami, A ^a   Mauceri, B ^a   Misseri, M ^a   Interlandi, D ^a   Cutuli, N ^a   Castellino, P ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

H63D mutation; Haemochromatosis; Iron; Liver histology; Non alcoholic; Steatohepatitis

Indexed keywords

HFE PROTEIN; IRON;

ADULT; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GENE MUTATION; GENETIC SCREENING; HEMOCHROMATOSIS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL;

FATTY LIVER; FEMALE; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PREVALENCE;

EID: 41549138894     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01474.x     Document Type: Article

References (20)

1. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002 122 : 1649 57.
2. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001 121 : 710 23.
3. Browning JD, Horton JD. Molecular mediator of hepatic steatosis and liver injury. J CIin Invest 2004 114 : 147 52.
4. Fargion S, Mattioli M, Fracanzani AL, Fiorelli G. Iron and liver diseases. Can J Gastroenterol 2000 14 Suppl. D : 89 92.
5. Pietrangelo A. Hereditary haemochromatosis. A new look at an old disease. N Engl J Med 2004 350 : 2383 97.
6. Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Haemochromatosis mutations in the general population: iron overload progression rate. Blood 2004 15 : 2914 19.
7. Chitturi S, Weltman M, Farrel CG, McDonald D, Kench J, Liddle C et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002 36 : 142 9.
8. Bonkovsky HL, Jawaid O, Tortorelli K, Leclair P, Cobb J. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999 31 : 421 9.
9. Deugnier Y, Moirand R, Jouanolle AM, LeGall SY, Brissot P, David V. HLA-H mutation in patients with iron overload and normal transferrin saturation. Hepatology 1997 26 : 199A.
10. Powell EE, Azmat A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM et al. Steatosis is a cofactor in liver injury in Haemochromatosis. Gastroenterology 2005 129 : 1937 43.
11. Brunt EM, Janney CG, Di Bisceglie AM, Neuchwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis; a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999 94 : 2467 74.
12. MacSween RNM, Antony PP, Scheuer PJ. Pathology of the Liver. Edinburgh : Churcill Livingstone 1987 185.
13. Wallace DF, Walker AP, Pietrangelo A, Clare M, Bomford AB, Dixon JL et al. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. J Hepatol 2002 36 : 474 9.
14. George DK, Powell LW, Losowsky MS. The haemochromatosis gene: a co-factor for chronic liver diseases? J Gastroenterol Hepatol 1999 14 : 745 9.
15. Thorburn D, Curry E, Spooner R, Spence E, Oien K, Hallas D et al. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 2002 50 : 249 52.
16. Pietrangelo A. Mechanism of iron toxicity. Adv Exp Med Biol 2002 509 : 19 43.
17. Adams LA, Angulo P, Abraham SC, Torgerson H, Brandhagen D. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary haemochromatosis. Liver Intern 2006 26 : 298 304.
18. Wilson JG. Iron and glucose homeostasis: new lessons from hereditary haemochromatosis. Diabetologia 2006 49 : 1459 61.
19. Shepherd PR, Soos MA, Siddle K. Inhibitors of phosphoinositide 3-kinase block exocytosis but not endocytosis of transferrin receptors in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1995 211 : 535 9.
20. Gross CN, Irrinki A, Feder JN, Enns CA. Co-trafficking of HFE, a neoclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem 1998 273 : 168 74.